For example, somatic point mutations of the E-cadherin gene [17] and/or promoter methylation lead to E-cadherin loss [20, 27], and the loss of E-cadherin expression is considered to be a distinguishing feature in both lobular breast cancer and diffuse gastric cancer [27, 28]. This evidence concerns the gene CDH1 and Hereditary breast cancer.